Summary
The product Supermed 10, manufactured by Deus Medical, was tested for potency. The sample, identified by batch number DM96530, was submitted by DEUSPOWER.COM and analyzed by Janoshik Analytical. The analysis confirmed the presence of Methyldrostanolone, with measured concentrations of 9.73 mg and 9.81 mg, slightly below the labeled 10 mg claim.
The testing process began on 7 July 2020, with analysis completed on 8 July 2020. While this result suggests good quality control, the submission process managed by a reseller highlights the need for broader product consistency evaluations.
Detailed Report
Product Overview
- Manufacturer: Deus Medical
- Product Name: Supermed 10
- Active Ingredient: Methyldrostanolone
- Batch Number: DM96530 (Manufactured: 05/2020)
- Expiration Date: Not provided
- Delivery Method: Oral
Sample Acquisition and Testing
- Task Number: #07036
- Testing Ordered: 7 July 2020
- Sample Received: 7 July 2020
- Analysis Conducted By: Janoshik Analytical
- Product Submitted By: DEUSPOWER.SHOP (Reseller)
- Analysis Paid For By: DEUSPOWER.SHOP (Reseller)
Testing Results
- Specification: 10 mg (as stated on the label)
- Measured Concentration: 9.73 mg & 9.81 mg
- Accuracy: 97.3% & 98.1% of the label claim
- Variance: -2.7% & -1.9%
Verification Details
- Verification URL: https://janoshik.com/tests/07036_JHC491CRYQEH
Evaluation of Reseller-Submitted Testing
This test result suggests strong manufacturing quality; however, as the sample was submitted by the reseller (DEUSPOWER.COM), it is possible that only high-quality batches were selected for testing. While Janoshik Analytical is a respected testing laboratory, third-party verification is necessary to ensure consistent dosing across multiple batches.
Consumers should approach reseller-funded test results with caution and seek independent testing sources where possible.
Conclusion
The analysis confirms that Supermed 10 by Deus Medical is accurately dosed, with a measured concentration of 9.73 mg – 9.81 mg, slightly under the labeled claim but still within an acceptable variance of 2.7%. This suggests good manufacturing standards, but as the test was submitted by a reseller, further independent testing is recommended to ensure uniformity across different batches.
This report is published as an educational and harm reduction resource to help consumers make informed choices when considering Methyldrostanolone-containing products.
Disclaimer
This report is published for educational and harm reduction purposes. While reseller-submitted testing can provide useful data, it may also be subject to bias.
Readers are encouraged to verify product consistency through multiple sources before making purchasing decisions.
